Alexandria Hammond
Stock Analyst at Wolfe Research
(0)
# 3101
Out of 5,235 analysts
13
Total ratings
33.33%
Success rate
6.78%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Regeneron Pharmaceut... | Initiates Coverage On: Outperform | 1150 | n/a | n/a | 1 | Nov 15, 2024 | |
Pfizer | Initiates Coverage On: Underperform | 25 | 27.12 | -7.82% | 1 | Nov 15, 2024 | |
Moderna | Initiates Coverage On: Underperform | 40 | 47.52 | -15.82% | 1 | Nov 15, 2024 | |
Merck & Co | Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
Eli Lilly | Initiates Coverage On: Outperform | 1000 | 773.09 | 29.35% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 190 | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 110 | 90.61 | 21.4% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 205 | 179.49 | 14.21% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 30 | 26.59 | 12.82% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 150 | 323.36 | -53.61% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 30 | n/a | n/a | 1 | Apr 22, 2024 |